All In MedTech

FDA Clearance Tracker · P970003-S046

NEUROCYBERNETIC PROSTHESIS (NCP) SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 30, 2003 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Sep 30, 2003

Approved

Time to decision

305 days

Received Nov 29, 2002. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P970003-S046
Device name
NEUROCYBERNETIC PROSTHESIS (NCP) SYSTEM
Applicant location
Houston, TX
Received
Nov 29, 2002
Decided
Sep 30, 2003
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P970003

Device type

Device class
Class III

Every decision under product code LYJ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR AN ALTERNATIVE STERILIZATION PROCESS (HYDROGEN PEROXIDE GAS PLASMA USING THE STERRAD 200 GMP STERILIZER) FOR THE MODEL 401 TUNNELER AND APPROVAL OF A PROTOCOL FOR B1 INCUBATION REDUCTION AND SHELF LIFE STUDY, AS WELL AS A NEW STERILIZATION FACILITY (CYBERONICS, INC., HOUSTON, TEXAS).

Source documents

Other decisions for LivaNova USA, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

4 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.